Molly Thomas
Christian Medical College & Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Molly Thomas.
Human & Experimental Toxicology | 1991
Jacob Peedicayil; Kalpana Ernest; Molly Thomas; A. S. Kanagasabapathy; P.M. Stephen
This paper presents the findings of a study of serum pseudocholinesterase activity in a group of 36 industrial workers chronically exposed to organophosphorus (OP) compounds. The mean pseudocholinesterase level of the workers was significantly lower than that of 36 other workers without a history of similar exposure. Although there was a high incidence of clinical features suggestive of OP compound toxicity in the exposed workers, no significant correlation between serum pseudocholinesterase levels and clinical symptoms and signs was found. Six exposed workers, found to have low serum pseudocholinesterase levels, were transferred for 6 months to work areas which did not involve OP exposure, whereupon their levels rose significantly back to the normal range.
Postgraduate Medical Journal | 2010
Molly Thomas; John Victor Peter; Abhilasha Williams; Victoria Job; Renu George
Background A number of dermatological conditions present with features of systemic inflammatory response syndrome (SIRS). This study evaluated the incidence and outcome of SIRS in patients with dermatological diseases. Study design Prospective cohort study. Results Patients admitted to a university hospital with a skin disease and fulfilling at least two SIRS criteria were included. The primary outcome measure was mortality. Secondary outcomes included incidence of multiple organ dysfunction syndrome (MODS), sepsis, severe sepsis and shock. Over 14 months, 2765 inpatients with skin related problems were examined. These included 721 patients admitted directly to the dermatology ward and 2044 patients referred from other departments within the hospital, with cutaneous manifestations. The incidence of SIRS in this cohort was 2.4% (n=67). The mean (SD) age was 32.6 (19.7) years with a male:female ratio of 1.2:1. Cutaneous adverse drug reaction (CADR) was the most common cause of SIRS (35.8%). During hospitalisation, 37 patients (55.2%) developed sepsis, 23 (34.4%) MODS, 15 (22.4%) severe sepsis and 6 (9%) shock. Methicillin sensitive Staphylococcus aureus was the most common skin isolate (41.4%) and Enterococcus the most common blood isolate. Overall mortality was 15% (10/67). Older age, low albumin, MODS, severe sepsis and shock were associated with an increased risk of death (p<0.03). Positive blood cultures, liver or lung involvement were also significantly associated with increased mortality (p<0.01). Conclusion The incidence of SIRS was low in dermatological diseases. In this cohort, CADR was the most common cause of SIRS. Patients who developed sepsis or MODS had a poor outcome.
Indian Journal of Dermatology, Venereology and Leprology | 2010
Molly Thomas; Renu George; Meera Thomas
Epidermolytic acanthoma (EA) is a rare benign tumor that shows epidermolytic hyperkeratosis (EH) on histopathology. It can occur in a solitary or disseminated form. This condition needs to be distinguished from other hereditary or acquired conditions that may show EH. We diagnosed an unusual case of EA of the vulva presenting in a linear pattern in a 50-year-old lady based on the clinical features and typical histopathological findings and stress the importance of considering epidermolytic acanthoma in the differential diagnosis of verrucous lesions of the genitalia.
Journal of The American Academy of Dermatology | 2011
Molly Thomas; J. Isaac Jebaraj; Meera Thomas; Renu George
REFERENCES 1. Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, Engler DE, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 2009;60:315-20. 2. Brink AA, Lloveras B, Nindl I, Heideman DA. Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 2005;43:5581-7. 3. Videla S, Darwich L, Ca~ nadas MP, Paredes R, Tarrats A, Castella E, et al. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J Acquir Immune Defic Syndr 2009;50:168-75. 4. Barzegar C, Paul C, Saiag P, Cassenot P, Bachelez H, Autran B, et al. Epidermodysplasiaverruciformis-likeeruptioncomplicatinghuman immunodeficiency virus infection. Br J Dermatol 1998;139:122-7. 5. Carr e D, Dompmartin A, Verdon R, Comez F, LeBrun E, Freymuth F, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol 2003;42:296-300.
Clinical Pharmacology & Therapeutics | 1991
Molly Thomas
Clinical Pharmacology and Therapeutics (1991) 49, 347–349; doi:10.1038/clpt.1991.39
Archive | 1989
Thomas Sen Bhanu; Mathew Thariyan; Molly Thomas
A double blind study to evaluate in allergic rhinitis the efficacy of Astemizole with a classical antihistaminic—Chlorpheneramine is described. The results indicate that there is a significantly better clinical improvement with Astemizole compared with Chlorpheneramine. Except of weight gain, adverse Cholinergic and sedative effects were also minimal with Astemizole.
Journal of Clinical Epidemiology | 1996
Molly Thomas; Shalini Govil; B.V. Moses; Abraham Joseph
Journal of Pharmacy and Pharmacology | 1983
Molly Thomas; Paul Turner
Sozial-und Praventivmedizin | 1994
Molly Thomas; Prabha Jairaj; Leni Grace Mathew
Advances in Applied Science Research | 2014
Francis Gricilda Shoba; Molly Thomas